Physician profile
Brendan F Johnson
NPI 1225653058
$9,290.20
in general payments reported to CMS, 2019-2025
27 companies · $4,528 in 2025
The $4,528 reported for 2025 was more than what 96% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $766 · 2021: $1,811 · 2022: $962 · 2023: $812 · 2024: $411 · 2025: $4,528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,881 · Travel and Lodging: $2,193 · Education: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,880.53 |
| Travel and Lodging | $2,192.56 |
| Education | $678.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ets Wound Care LLC | $2,614.28 | 2025 | Mirragen Advanced Wound Matrix |
| Rock Medical Orthopedics, INC. | $1,917.36 | 2020-2021 | |
| Treace Medical Concepts, INC. | $1,657.93 | 2023-2025 | |
| Stryker Corporation | $562.03 | 2021-2024 | Augment Injectable, Ortholoc 3di, Hoffmann |
| Integra Lifesciences Corporation | $449.55 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $425.42 | 2022-2023 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $197.93 | 2023-2024 | Motoband, Na, Va-Lcp |
| Aroa Biosurgery Incorporated | $158.52 | 2022-2025 | |
| Kerecis Limited | $151.68 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bioventus LLC | $145.67 | 2022-2023 | Stimrouter Implantable Kit |
| Acera Surgical, INC. | $133.74 | 2025 | Restrata Wound Matrix |
| Angiodynamics, INC. | $126.75 | 2021 | |
| Horizon Therapeutics Plc | $124.99 | 2022 | |
| Fusion Orthopedics USA, LLC | $116.42 | 2025 | |
| Solventum Corporation | $85.89 | 2024 | Activ.A.C., V.A.C.Instill |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $72.27 | 2021 | |
| Smith+Nephew, INC. | $68.69 | 2020-2025 | Collagenase Santyl, Pico 7 |
| Grt US Holding, INC. | $55.81 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $43.91 | 2021 | |
| Melinta Therapeutics, LLC | $42.00 | 2020-2022 | |
| Paragon 28, INC. | $36.75 | 2020 | |
| Arteriocyte Medical Systems, INC. | $29.16 | 2021 | |
| Hydrofera LLC | $21.44 | 2024 | Hydrofera Blue |
| Paratek Pharmaceuticals, INC. | $21.31 | 2023 | Nuzyra |
| Heron Therapeutics, INC. | $16.18 | 2021 | |
| Orthofix Medical, INC. | $10.54 | 2020 | |
| Microaire Surgical Instruments LLC | $3.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.